The Point-of-care Diagnostics Market is expected to reach $82.74 billion by 2029, at a CAGR of 7.4% from 2022 to 2029. Point-of-care (POC), often known as bedside testing, refers to any type of diagnostic test that is not performed in a laboratory. More precisely, this type of testing is done as close to the patient as possible. Modern medical advances have made it feasible to easily and quickly assess a wide range of health factors to make the screening, evaluation, diagnosis, therapy, and prognoses as efficient as possible. Unlike the traditional laboratory technique, which includes an analytical, preanalytical, and post-analytical phase, point-of-care testing eliminates all but the analytical step, considerably lowering the risk of potential errors.
The demand for point-of-care diagnosis has increased significantly in the last ten years as the demand for reliable and timely testing has grown both within and outside the hospital environment. Factors such as the increased availability of portable, transportable, and handheld devices have significantly contributed to the shift of testing from hospitals to a variety of medical settings such as the home, workplace, emergency care, and, most notably, convenience clinics.
In addition, the growing prevalence of infectious illnesses and chronic ailments such as cardiovascular disease and diabetes in emerging nations such as India and China has increased the demand for point-of-care diagnostics. For instance, according to the International Diabetes Federation, in 2021, nearly 537 million adults (20–79 years) were living with diabetes globally. This figure is projected to rise to 643 million by 2030 and 783 million by 2045. Furthermore, in South East Asia, in 2021, around 90 million people were living with diabetes, and this number is expected to increase to 113 million by 2030. Thus, the increasing need for early diagnosis is projected to drive the growth of the point-of-care diagnostics market.
Click here to: Get Free Sample Copy of this report
The Impact of COVID-19 on the Point-of-care Diagnostics Market
The COVID-19 pandemic adversely affected various sectors globally. According to the WHO, over 613 million cases of COVID-19 infections were reported as of September 2022. This number is still growing, and the pandemic duration is still unclear. However, the COVID-19 pandemic increased public health awareness worldwide, positively impacting the growth of the point-of-care diagnostics market. Point-of-care testing has become an essential diagnostic tool due to the need for quick diagnostic results. The discovery of new coronavirus strains has boosted research and development efforts in the point-of-care diagnostics sector. The pandemic has significantly influenced the point-of-care diagnostics industry, and companies strive to develop quick and accurate viral detection technologies. The outbreak of the COVID-19 pandemic has increased the demand for portable and transportable devices, and manufacturers worldwide are rushing to develop next-generation point-of-care platforms that are quicker, simpler, and more reliable.
Increasing Outbreaks of Diseases to Drive the Market Growth
Frequent disease outbreaks in developing and low-income countries have resulted in high demand for point-of-care diagnostics. The COVID-19 pandemic has highlighted the importance of rapid diagnostics tools. According to the WHO, in 2020, a total of 1.5 million people died from TB (including 214 000 people infected with HIV). India has the highest incidence rate of tuberculosis globally, with an estimated occurrence of 2.64 million cases in 2020. Thus, the increasing outbreaks of diseases are expected to increase the adoption of POC diagnostic kits during the forecast period, subsequently driving the market's growth.
Key Findings in the Point-of-care Diagnostics Market Study:
The Infectious Diseases Segment to Generate the Majority of Revenue in 2022
In recent years, the increasing global burden of infectious diseases has significantly fueled the demand for quick and accurate diagnostics tests. According to the Institute for Health Metrics and Evaluation’s Global Burden of Disease (2019), the number of individuals with cardiovascular diseases was estimated at 393 million. Similarly, the global burden of respiratory infections and TB recorded over 153 million cases in 2019. Moreover, HIV/AIDS and STI cases reached up to 57 million in 2019. These numbers are expected to increase due to the consumption of unhealthy diets, an increase in pollution, and low immunity levels. In order to curb the increasing cases and spread of infection, healthcare authorities worldwide are authorizing the use of point-of-care testing in healthcare, clinics, and ambulatory healthcare settings. Furthermore, the increasing disease outbreaks contribute to this segment's growth.
The Lateral Flow Assays Segment is Expected to Account for the Largest Market Share in 2022
The large market share of this segment is attributed to the affordability and clinical utility offered by lateral flow assays in point-of-care applications. The point-of-care diagnostics market for lateral flow assays has increased significantly in recent years due to the rising use of these assays in home care settings. Companies are actively working on the development of novel LFA-based PoC devices for the testing of pregnancies and ovulation. Furthermore, PoC tests based on lateral flow assays are increasingly being used to replace traditional laboratory procedures, which are time-consuming.
The Over-the-Counter (OTC) Segment is Slated to Register the Highest CAGR During the Forecast Period
The demand for over-the-counter point-of-care test kits and devices is driven by the increasing adoption of self-testing in home care settings. Furthermore, the increasing number of product approvals by the FDA and new product launches by major market players also support this segment’s growth. In addition, the increasing adoption of at-home pregnancy tests and blood glucose monitoring devices has increased the demand for over-the-counter diagnostic kits.
Most diabetes patients worldwide prefer to check blood glucose levels on their own. Furthermore, the ease of use offered by advanced OTC blood glucose monitoring devices drives their demand in the market. Furthermore, emergency FDA approvals of rapid COVID-19 test kits such as Quidel QuickVue At-Home OTC COVID-19 test, Abbott BinaxNOW COVID-19 Antigen Self-Test, Abbott BinaxNOW COVID-19 Ag Card 2 Home Test, and BD Veritor System for Rapid Detection of SARS-CoV-2 significantly increased the segment’s share during the pandemic period.
The Home Care/Self-testing Segment is Expected to Register Significant Growth During the Forecast Period
The availability of cost-effective point-of-care testing devices and the growing awareness of the importance of routine health monitoring is expected to increase the demand for point-of-care diagnostics devices during the forecast period. Furthermore, the market is being driven by the increasing adoption of preventive testing/monitoring devices for blood glucose and blood pressure. In addition, the entry of new market players with advanced technologies contributes to the growth of the point-of-care diagnostics market for home care/self-testing applications.
The Market in Asia-Pacific is Slated to Register the Highest CAGR During the Forecast Period
The growth in this regional market is driven by the rising number of local producers of point-of-care diagnostic products, the growing investments by major market players, the rising geriatric population in countries such as India and China, and the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases.
According to the International Dental Federation (IDF), in 2021, China led in terms of diabetic population with over 140 million cases, followed by India with over 74 million cases. Furthermore, China is the highest populated country in the world, and there is a major concern about the rising aging population in the country. According to the WHO, the population of people aged over 60 years in China is projected to reach 28% by 2040. The rise in the aging population is expected to increase the demand for devices for monitoring blood glucose levels, blood pressure, and cholesterol levels, subsequently driving the growth of the point-of-care diagnostics market.
Some of the key players operating in the global point-of-care diagnostics market are Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Quidel Corporation (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), CHEMBIO DIAGNOSTICS, INC. (U.S.), EKF Diagnostics (U.K.), Trinity Biotech plc (Ireland), Werfen, S.A. (Spain), Nova Biomedical (U.S.), Sekisui Diagnostics (U.S.), Thermo Fisher Scientific (U.S.), and bioMérieux S.A. (France).
Scope of the Report:
Point-of-care Diagnostics Market, by Application
Point-of-care Diagnostics Market, by Platform
Point-of-care Diagnostics Market, by Mode of Purchase
Point-of-care Diagnostics Market, by End User
Point-of-care Diagnostics Market, by Geography
Key Questions Answered in the Report:
This study offers a detailed assessment of the point-of-care diagnostics market, including the market sizes & forecasts based on application, platform, mode of purchase, and end user. The point-of-care diagnostics market study also provides the value analysis of various segments and subsegments of the point-of-care diagnostics market at the regional and country levels.
The point-of-care diagnostics market is projected to reach $82.74 billion by 2029, at a CAGR of 7.4% during the forecast period.
Based on application, in 2022, the infectious diseases testing segment is estimated to hold the largest market share.
Based on platform, in 2022, the lateral flow assays segment is expected to account for the largest share of the market. The affordability and clinical utility offered by lateral flow assays in point-of-care applications contribute to the large market share of this segment.
The growth of this market is driven by the increasing prevalence of infectious and non-infectious diseases. Furthermore, the high demand for point-of-care diagnostics from emerging countries is expected to offer significant opportunities for the growth of this market
The key players operating in the point-of-care diagnostics market are Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Quidel Corporation (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), CHEMBIO DIAGNOSTICS, INC. (U.S.), EKF Diagnostics (U.K.), Trinity Biotech plc (Ireland), Werfen, S.A. (Spain), Nova Biomedical (U.S.), Sekisui Diagnostics (U.S.), Thermo Fisher Scientific (U.S.), and bioMérieux S.A. (France).
Emerging economies such as China and India are expected to offer significant growth opportunities for the market players due to the high prevalence of infectious diseases in these countries.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing Prevalence of Chronic Diseases
4.2.1.2. Rapidly Growing Demand for Cost-effective and Innovative PoC Tests
4.2.2. Restraints
4.2.2.1. Presence of Stringent Regulatory Policies
4.2.2.1. Pricing Pressures due to Reimbursement Cuts and Budget Constraints
4.2.3. Opportunities
4.2.3.1. Growth Opportunities in Emerging Markets
4.2.3.2. PoC Tests with Multiplexing Capabilities
4.2.3.3. Healthcare Transition Converting Lab Tests to PoC Tests
4.2.4. Challenges
4.2.4.1. Lack of Knowledge About the Use of PoC Devices
4.3. Impact of the COVID-19 Pandemic on the Point-of-Care Diagnostics Market
5. Global Point-of-Care Diagnostics Market, by Application
5.1. Introduction
5.2. Infectious Diseases Testing
5.2.1. Respiratory Infections Testing
5.2.1.1. Influenza
5.2.1.2. Tuberculosis (TB)
5.2.1.3. Pneumonia
5.2.1.4. Other Respiratory Infections
5.2.2. Healthcare-Associated Infection (HAI) Testing
5.2.3. Parasitic Infections
5.2.4. Gastrointestinal Infections
5.2.4.1. Salmonellosis
5.2.4.2. E. Coli Infections
5.2.4.3. Other GI Infections
5.2.5. Blood-borne Infections Testing
5.2.5.1. Hepatitis
5.2.5.2. HIV
5.2.5.3. Other Blood-borne Infections
5.2.6. Other Infectious Disease Testing
5.3. Blood Glucose Monitoring Products
5.3.1. Test Strips
5.3.2. Glucometers
5.3.3. Lancets & Lancing Devices
5.3.4. Hemoglobin A1c Test Kits
5.4. Cardiac Marker/Cardiac Metabolism Testing
5.5. COVID-19 Testing
5.6. Coagulation Testing
5.6.1. Prothrombin Time (PT/INR) Test
5.6.2. Activated Clotting Time (ACT/aPTT) Test
5.6.3. Other Tests
5.7. Pregnancy and Fertility Testing
5.7.1. Pregnancy Test
5.7.2. Fertility Test
5.8. Fecal Occult Testing
5.9. Hematology
5.10. Tumor/Cancer Markers Testing
5.11. Drugs of Abuse Test
5.12. Urinalysis
5.13. Cholesterol/lipid profile Testing
5.14. Other PoC Test
6. Global Point-of-Care Diagnostics Market, by Platform
6.1. Introduction
6.2. Lateral Flow Assays
6.3. Molecular Diagnostics
6.4. Other Platforms
7. Global Point-of-Care Diagnostics Market, by Mode of Purchase
7.1. Introduction
7.2. Prescription-based Tests
7.3. Over-the-Counter (OTC) Tests
8. Global Point-of-Care Diagnostics Market, by End User
8.1. Introduction
8.2. Home Care/Self Testing
8.3. Hospitals
8.4. Physician offices & Ambulatory Care Settings
8.5. Diagnostics Labs
8.6. Other End Users
9. Point-of-Care Diagnostics Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America (LATAM)
9.5.1. Brazil
9.5.2. Mexico
9.5.3 Rest of Latin America (RoLATAM)
9.6. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3 Competitive Benchmarking
10.4. Market Share Analysis (2021)
11. Company Profiles (Business Overview, Financial Snapshot, Product Portfolio, Strategic Developments)
11.1. Abbott Laboratories
11.2. Siemens Healthineers AG
11.3. Quidel Corporation
11.4. F. Hoffman-La Roche Ltd.
11.5. Danaher Corporation
11.6. Becton, Dickinson and Company
11.7. CHEMBIO DIAGNOSTICS, INC.
11.8. EKF Diagnostics
11.9. Trinity Biotech plc
11.10. Instrumentation Laboratory
11.11. Nova Biomedical
11.12. Sekisui Diagnostics
11.13. Thermo Fisher Scientific
11.14. bioMérieux S.A.
12. Appendix
12.1. Questionnaire
12.2. Available Customization
List of Tables
Table 1 Global Point-of-Care Diagnostics Market Drivers: Impact Analysis (2022–2029)
Table 2 Global Point-of-Care Diagnostics Market Restraints: Impact Analysis (2022–2029)
Table 3 Global Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 4 Global Point-of-Care Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million)
Table 5 Global Point-of-Care Diagnostics Market Size for Infectious Diseases Testing, by Country/Region, 2020–2029 (USD Million)
Table 6 Global Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 7 Global Point-of-Care Diagnostics Market Size for Respiratory Infection, by Country/Region, 2020–2029 (USD Million)
Table 8 Global Point-of-Care Diagnostics Market Size for Influenza, by Country/Region, 2020–2029 (USD Million)
Table 9 Global Point-of-Care Diagnostics Market Size for Tuberculosis (TB), by Country/Region, 2020–2029 (USD Million)
Table 10 Global Point-of-Care Diagnostics Market Size for Pneumonia, by Country/Region, 2020–2029 (USD Million)
Table 11 Global Point-of-Care Diagnostics Market Size for Other Respiratory Infections, by Country/Region, 2020–2029 (USD Million)
Table 12 Global Point-of-Care Diagnostics Market Size for Healthcare Associated Infection (HAI) Testing, by Country/Region, 2020–2029 (USD Million)
Table 13 Global Point-of-Care Diagnostics Market Size for Parasitic Infections, by Country/Region, 2020–2029 (USD Million)
Table 14 Global Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 15 Global Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Country/Region, 2020–2029 (USD Million)
Table 16 Global Point-of-Care Diagnostics Market Size for Salmonellosis, by Country/Region, 2020–2029 (USD Million)
Table 17 Global Point-of-Care Diagnostics Market Size for E. Coli Infection, by Country/Region, 2020–2029 (USD Million)
Table 18 Global Point-of-Care Diagnostics Market Size for Other GI Infections, by Country/Region, 2020–2029 (USD Million)
Table 19 Global Point-of-Care Diagnostics Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million)
Table 20 Global Point-of-Care Diagnostics Market Size for Blood-borne Infections, by Country/Region, 2020–2029 (USD Million)
Table 21 Global Point-of-Care Diagnostics Market Size for Hepatitis, by Country/Region, 2020–2029 (USD Million)
Table 22 Global Point-of-Care Diagnostics Market Size for HIV, by Country/Region, 2020–2029 (USD Million)
Table 23 Global Point-of-Care Diagnostics Market Size for Other Blood-borne Infections, by Country/Region, 2020–2029 (USD Million)
Table 24 Global Point-of-Care Diagnostics Market Size for Other Infectious Disease Test, by Country/Region, 2020–2029 (USD Million)
Table 25 Global Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 26 Global Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Country/Region, 2020–2029 (USD Million)
Table 27 Global Point-of-Care Diagnostics Market Size for Test Strips, by Country/Region, 2020–2029 (USD Million)
Table 28 Global Point-of-Care Diagnostics Market Size for Glucometers, by Country/Region, 2020–2029 (USD Million)
Table 29 Global Point-of-Care Diagnostics Market Size for Lancets, by Country/Region, 2020–2029 (USD Million)
Table 30 Global Point-of-Care Diagnostics Market Size for Hemoglobin A1c Test Kits, by Country/Region, 2020–2029 (USD Million)
Table 31 Global Point-of-Care Diagnostics Market Size for Cardiac Marker/Cardiac Metabolism Testing, by Country/Region, 2020–2029 (USD Million)
Table 32 Global Point-of-Care Diagnostics Market Size for COVID-19 Testing, by Country/Region, 2020–2029 (USD Million)
Table 33 Global Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 34 Global Point-of-Care Diagnostics Market Size for Coagulation Test, by Country/Region, 2020–2029 (USD Million)
Table 35 Global Point-of-Care Diagnostics Market Size for Prothrombin Time (PT/INR) Test, by Country/Region, 2020–2029 (USD Million)
Table 36 Global Point-of-Care Diagnostics Market Size for Activated Clotting Time (ACT/aPTT) Test, by Country/Region, 2020–2029 (USD Million)
Table 37 Global Point-of-Care Diagnostics Market Size for Other Tests, by Country/Region, 2020–2029 (USD Million)
Table 38 Global Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 39 Global Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Country/Region, 2020–2029 (USD Million)
Table 40 Global Point-of-Care Diagnostics Market Size for Pregnancy Test, by Country/Region, 2020–2029 (USD Million)
Table 41 Global Point-of-Care Diagnostics Market Size for Fertility Test, by Country/Region, 2020–2029 (USD Million)
Table 42 Global Point-of-Care Diagnostics Market Size for Fecal Occult Test, by Country/Region, 2020–2029 (USD Million)
Table 43 Global Point-of-Care Diagnostics Market Size for Hematology Test, by Country/Region, 2020–2029 (USD Million)
Table 44 Global Point-of-Care Diagnostics Market Size for Tumor/Cancer Markers Test, by Country/Region, 2020–2029 (USD Million)
Table 45 Global Point-of-Care Diagnostics Market Size for Drugs of Abuse Test, by Country/Region, 2020–2029 (USD Million)
Table 46 Global Point-of-Care Diagnostics Market Size for Urinalysis Test, by Country/Region, 2020–2029 (USD Million)
Table 47 Global Point-of-Care Diagnostics Market Size for Cholesterol/lipid profile Testing Products, by Country/Region, 2020–2029 (USD Million)
Table 48 Global Point-of-Care Diagnostics Market Size for Other PoC Test, by Country/Region, 2020–2029 (USD Million)
Table 49 Global Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 50 Global Point-of-Care Diagnostics Market Size for Lateral Flow Assays, by Country/Region, 2020–2029 (USD Million)
Table 51 Global Point-of-Care Diagnostics Market Size for Molecular Diagnostics, by Country/Region, 2020–2029 (USD Million)
Table 52 Global Point-of-Care Diagnostics Market Size for Other Platforms, by Country/Region, 2020–2029 (USD Million)
Table 53 Global Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 54 Global Point-of-Care Diagnostics Market Size for Prescription-based Test, by Country/Region, 2020–2029 (USD Million)
Table 55 Global Point-of-Care Diagnostics Market Size for Over-the-Counter (OTC) Test, by Country/Region, 2020–2029 (USD Million)
Table 56 Global Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 57 Global Point-of-Care Diagnostics Market Size for Home Care/Self Testing, by Country/Region, 2020–2029 (USD Million)
Table 58 Global Point-of-Care Diagnostics Market Size for Hospitals, by Country/Region, 2020–2029 (USD Million)
Table 59 Global Point-of-Care Diagnostics Market Size for Physician offices & Ambulatory Care Settings, by Country/Region, 2020–2029 (USD Million)
Table 60 Global Point-of-Care Diagnostics Market Size for Diagnostics Labs, by Country/Region, 2020–2029 (USD Million)
Table 61 Global Point-of-Care Diagnostics Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million)
Table 62 Global Point-of-Care Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 63 North America: Point-of-Care Diagnostics Market Size, by Country, 2020–2029 (USD Million)
Table 64 North America: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 65 North America: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 66 North America: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 67 North America: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 68 North America: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 69 North America: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 70 North America: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 71 North America: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 72 North America: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 73 North America: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 74 North America: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 75 U.S.: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 76 U.S.: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 77 U.S.: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 78 U.S.: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 79 U.S.: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 80 U.S.: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 81 U.S.: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 82 U.S.: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 83 U.S.: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 84 U.S.: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 85 U.S.: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 86 Canada: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 87 Canada: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 88 Canada: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 89 Canada: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 90 Canada: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 91 Canada: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 92 Canada: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 93 Canada: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 94 Canada: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 95 Canada: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 96 Canada: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 97 Europe: Point-of-Care Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 98 Europe: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 99 Europe: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 100 Europe: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 101 Europe: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 102 Europe: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 103 Europe: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 104 Europe: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 105 Europe: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 106 Europe: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 107 Europe: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 108 Europe: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 109 Germany: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 110 Germany: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 111 Germany: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 112 Germany: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 113 Germany: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 114 Germany: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 115 Germany: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 116 Germany: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 117 Germany: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 118 Germany: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 119 Germany: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 120 U.K.: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 121 U.K.: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 122 U.K.: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 123 U.K.: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 124 U.K.: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 125 U.K.: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 126 U.K.: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 127 U.K.: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 128 U.K.: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 129 U.K.: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 130 U.K.: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 131 France: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 132 France: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 133 France: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 134 France: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 135 France: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 136 France: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 137 France: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 138 France: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 139 France: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 140 France: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 141 France: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 142 Italy: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 143 Italy: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 144 Italy: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 145 Italy: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 146 Italy: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 147 Italy: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 148 Italy: Point-of-Care Diagnostics Market Size for Coagulation Monitoring Products, by Type, 2020–2029 (USD Million)
Table 149 Italy: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 150 Italy: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 151 Italy: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 152 Italy: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 153 Spain: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 154 Spain: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 155 Spain: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 156 Spain: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 157 Spain: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 158 Spain: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 159 Spain: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 160 Spain: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 161 Spain: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 162 Spain: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 163 Spain: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 164 Rest of Europe: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 165 Rest of Europe: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 166 Rest of Europe: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 167 Rest of Europe: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 168 Rest of Europe: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 169 Rest of Europe: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 170 Rest of Europe: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 171 Rest of Europe: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 172 Rest of Europe: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 173 Rest of Europe: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 174 Rest of Europe: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 175 Asia-Pacific: Point-of-Care Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 176 Asia-Pacific: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 177 Asia-Pacific: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 178 Asia-Pacific: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 179 Asia-Pacific: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 180 Asia-Pacific: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 181 Asia-Pacific: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 182 Asia-Pacific: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 183 Asia-Pacific: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 184 Asia-Pacific: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 185 Asia-Pacific: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 186 Asia-Pacific: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 187 China: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 188 China: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 189 China: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 190 China: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 191 China: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 192 China: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 193 China: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 194 China: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 195 China: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 196 China: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 197 Japan: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 198 Japan: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 199 Japan: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 200 Japan: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 201 Japan: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 202 Japan: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 203 Japan: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 204 Japan: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 205 Japan: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 206 Japan: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 207 India: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 208 India: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 209 India: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 210 India: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 211 India: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 212 India: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 213 India: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 214 India: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 215 India: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 216 India: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 217 Rest of Asia-Pacific: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 218 Rest of Asia-Pacific: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 219 Rest of Asia-Pacific: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 220 Rest of Asia-Pacific: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 221 Rest of Asia-Pacific: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 222 Rest of Asia-Pacific: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 223 Rest of Asia-Pacific: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 224 Rest of Asia-Pacific: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 225 Rest of Asia-Pacific: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 226 Rest of Asia-Pacific: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 227 Latin America: Point-of-Care Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 228 Latin America: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 229 Latin America: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 230 Latin America: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 231 Latin America: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 232 Latin America: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 233 Latin America: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 234 Latin America: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 235 Latin America: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 236 Latin America: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 237 Latin America: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 238 Latin America: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 239 Brazil: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 240 Brazil: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 241 Brazil: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 242 Brazil: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 243 Brazil: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 244 Brazil: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 245 Brazil: Point-of-Care Diagnostics Market Size for Coagulation Monitoring Products, by Type, 2020–2029 (USD Million)
Table 246 Brazil: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 247 Brazil: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 248 Brazil: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 249 Brazil: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 250 Mexico: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 251 Mexico: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 252 Mexico: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 253 Mexico: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 254 Mexico: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 255 Mexico: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 256 Mexico: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 257 Mexico: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 258 Mexico: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 259 Mexico: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 260 Mexico: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 261 Rest of Latin America: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 262 Rest of Latin America: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 263 Rest of Latin America: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 264 Rest of Latin America: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 265 Rest of Latin America: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 266 Rest of Latin America: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 267 Rest of Latin America: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 268 Rest of Latin America: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 269 Rest of Latin America: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 270 Rest of Latin America: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 271 Rest of Latin America: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 272 Middle East & Africa: Point-of-Care Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 273 Middle East & Africa: Point-of-Care Diagnostics Market Size for Infectious Disease Testing, by Type, 2020–2029 (USD Million)
Table 274 Middle East & Africa: Point-of-Care Diagnostics Market Size for Respiratory Infection, by Type, 2020–2029 (USD Million)
Table 275 Middle East & Africa a: Point-of-Care Diagnostics Market Size for Gastrointestinal Infections, by Type, 2020–2029 (USD Million)
Table 276 Middle East & Africa: Point-of-Care Diagnostics Market Size for Blood-borne Infections Test, by Type, 2020–2029 (USD Million)
Table 277 Middle East & Africa: Point-of-Care Diagnostics Market Size for Blood Glucose Monitoring, by Type, 2020–2029 (USD Million)
Table 278 Middle East & Africa: Point-of-Care Diagnostics Market Size for Coagulation Test, by Type, 2020–2029 (USD Million)
Table 279 Middle East & Africa: Point-of-Care Diagnostics Market Size for Pregnancy and Fertility Test, by Type, 2020–2029 (USD Million)
Table 280 Middle East & Africa: Point-of-Care Diagnostics Market Size, by Platform, 2020–2029 (USD Million)
Table 281 Middle East & Africa: Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2020–2029 (USD Million)
Table 282 Middle East & Africa: Point-of-Care Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 283 Recent Developments, by Company (2020–2022)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Point-of-Care Diagnostics Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 8 Global Point-of-Care Diagnostics Market Size, by Platform, 2022 Vs. 2029 (USD Million)
Figure 9 Global Point-of-Care Diagnostics Market Size, by Mode of Purchase, 2022 Vs. 2029 (USD Million)
Figure 10 Global Point-of-Care Diagnostics Market Size, by End User, 2022 Vs. 2029 (USD Million)
Figure 11 Point-of-Care Diagnostics Market, by Region
Figure 12 Market Dynamics
Figure 13 Global Point-of-Care Diagnostics Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 14 Global Point-of-Care Diagnostics Market Size, by Platform, 2022 Vs. 2029 (USD Million)
Figure 15 Global Point-of-Care Diagnostics Market Size, by Mode, 2022 Vs. 2029 (USD Million)
Figure 16 Global Point-of-Care Diagnostics Market Size, by End User, 2022 Vs. 2029 (USD Million)
Figure 17 Global Point-of-Care Diagnostics Market Size, by Region, 2022 Vs. 2029 (USD Million)
Figure 18 North America: Point-of-Care Diagnostics Market Snapshot
Figure 19 Europe: Point-of-Care Diagnostics Market Snapshot
Figure 20 Asia-Pacific: Point-of-Care Diagnostics Market Snapshot
Figure 21 Latin America: Point-of-Care Diagnostics Market Snapshot
Figure 22 Competitive Benchmarking: Point-of-Care Diagnostics Market: Based on Platform
Figure 23 Competitive Benchmarking: Point-of-Care Diagnostics Market: Based on Geography
Figure 24 Market Share Analysis: Point-of-Care Diagnostics Market (2021)
Figure 25 Abbott Laboratories: Financial Overview (2021)
Figure 26 Siemens Healthineers AG: Financial Overview (2021)
Figure 27 Quidel Corporation: Financial Overview (2021)
Figure 28 F. Hoffman-La Roche Ltd.: Financial Overview (2021)
Figure 29 Danaher Corporation: Financial Overview (2021)
Figure 30 Becton, Dickinson and Company: Financial Overview (2021)
Figure 31 EKF Diagnostics: Financial Overview (2021)
Figure 32 Trinity Biotech plc: Financial Overview (2021)
Figure 33 Instrumentation Laboratory (a Werfen Company): Financial Overview (2021)
Figure 34 Thermo Fisher Scientific: Financial Overview (2021)
Figure 35 bioMérieux S.A.: Financial Overview (2021)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jan-2023
Published Date: Oct-2022
Published Date: Sep-2022
Published Date: Jun-2022
Published Date: May-2022
